Dismantling mandates in the treatment of heart failure

Journal of the American College of Cardiology

Volumn 44, Issue 9, 2004, Pages 1831-1833

  Leier, Carl V ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; DIURETIC AGENT; ENALAPRIL; LOOP DIURETIC AGENT; VASODILATOR AGENT;

ACUTE HEART FAILURE; ADD ON THERAPY; BETA ADRENERGIC RECEPTOR BLOCKING; DISEASE CLASSIFICATION; DRUG EFFECT; EVIDENCE BASED MEDICINE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; MEDICAL SPECIALIST; NOTE; PRIORITY JOURNAL;

EID: 7044220419     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.08.013     Document Type: Editorial

References (19)

1. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
2. The CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study N Engl J Med 16 1987 1429 1435
3. The SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced ejection fractions N Engl J Med 327 1992 685 691
4. J.N. Cohn, G. Johnson, S Ziesche A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure N Engl J Med 325 1991 303 310
5. M.A. Pfeffer, E. Braunwald, L.A Moye Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial N Engl J Med 327 1992 669 677
6. Ambrosioni E, Borghi C, Magnani B, for the Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1195;332:80-5.
7. L. Kober, C. Torp-Pedersen, J.E Carlsen A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 333 1995 1670 1676
8. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure Lancet 342 1993 821 828
9. The American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary J Am Coll Cardiol 38 2001 2101 2113
10. The Practice Guidelines Committee Heart Failure Society of America guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - pharmacological approaches J Card Fail 5 1999 357 382
11. M. Packer, J.N. Cohn Advisory Council to Improve Outcomes Nationwide in Heart Failure Consensus recommendations for the management of chronic heart failure Am J Cardiol 83 1999 1A 38A
12. A.P. Maggioni, I. Anand, S.O. Gottlieb, R. Latini, G. Tognoni, J.N. Cohn Val-HeFT Investigators Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors J Am Coll Cardiol 40 2002 1414 1421
13. M.A. Pfeffer, J.J. McMurray, E.J., et al Velazquez., for the Valsartan in Acute Myocardial Infarction Trial Investigators Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction or both N Engl J Med 349 2003 1893 1906
14. C.B. Granger, J.J. McMurray, S Yusuf Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial Lancet 362 2003 772 776
15. A. Noori, J. Lindenfeld, E. Wolfel, D. Ferguson, M.R. Bristow, B.D. Lowes Beta-blockade in adriamycin-induced cardiomyopathy J Card Fail 6 2000 115 119
16. Sliwa K, Norton GR, Kone N, et al. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure. J Am Coll Cardiol 2004;44:1825-30.
17. H. Boudoulas, R.P. Lewis, S.E. Rittgers, C.V. Leier, J.S. Vasko Increased diastolic time: an important factor in the beneficial effect of propranolol in patients with coronary artery disease J Cardiovasc Pharmacol 1 1979 503 513
18. R. Garg, S. Yusuf Collaborative Group on ACE Inhibitor Trials Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure JAMA 273 1995 1450 1456
19. J.N. Cohn, D.G. Archibald, S Ziesche Effect of vasodilator therapy on mortality in chronic congestive heart failure N Engl J Med 314 1986 1547 1552